Clincosm LogoSign in Get a demo

metastatic hormone refractory prostate cancer

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Metastatic Hormone Refractory Prostate Cancer Trial in Worldwide (Patupilone, prednisone, docetaxel)

Completed
  • Metastatic Hormone Refractory Prostate Cancer
  • La Jolla, California
  • +31 more
Dec 11, 2020

Metastatic Hormone Refractory Prostate Cancer Trial in Nerviano (PHA-739358)

Completed
  • Metastatic Hormone Refractory Prostate Cancer
  • Nerviano, Milano, Italy
    Nerviano Medical Sciences. Clinical Research Dept.
May 13, 2014

Molecular, Genetic, and Genomic Assessments From Patients

Completed
  • Metastatic Hormone Refractory Prostate Cancer
    • Durham, North Carolina
      Duke University Medical Center
    Dec 3, 2013